Herbas VPB

Print
EN | LT
LT - INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER
EN - INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/436 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/08 (2006.01)
A61K 47/34 (2013.01)
A61K 47/10 (2017.01)
A61K 9/08 (2013.01)
A61K 47/18 (2017.01)
A61K 31/436 (2013.01)
A61K 47/20 (2006.01)
A61P 35/00 (2018.01)
A61K 45/06 (2013.01)
A61K 47/22 (2006.01)
A61K 47/24 (2006.01)
A61K 47/26 (2006.01)
A61K 47/34 (2017.01)
A61K 47/36 (2006.01)
A61P 35/00 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 3565553
(13) Kind of document T
(96) European patent application number 17890478.5
Date of filing the European patent application 2017-12-29
(97) Date of publication of the European application 2019-11-13
(45) Date of publication and mention of the grant of the patent 2023-04-26
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/JP2017/047408
Date 2017-12-29
PCT application publication
(87) Number WO 2018/128173
Date 2018-07-12
Priority applications
(30) Number Date Country code
201762443599 P 2017-01-06 US
Inventors
(72)
KUNDU, Aishwarya , US
ESCUDERO, Cecile , US
MUDUMBA, Sreenivasu , US
Grantee
(73) Santen Pharmaceutical Co., Ltd. , 9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP
Title
(54) INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER
  INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER